In terms of cancer suppression, studies have demonstrated that, on the one hand, PPARα limits the process of mitochondrial oxidative phosphorylation (OXPHOS), and non-tumor cells are not affected by it; on the other hand, PPARα increases the production of ROS, leading to the accumulation of mitochondrial oxidative stress in melanoma cells. The gene discussed is PPARA; the disease is melanoma.